has tirzepatide been fda approved is FDA-approved for weight management, with clinical trials showing average weight loss of 15–22.5% over 72 weeks. It's a prescription-only therapy, meaning it's not for everyone, and it works by acting RxConnection | FDA Approves New
Description
Extended-release exenatide (Bydureon BCise), given weekly, uses a microsphere suspension that may cause more injection site nodules (reported in 10.5% of patients according to its FDA label) compared to solution-based formulations

Your price won'tPlexusDx maintains flat monthly pricing at $149 regardless of which dose level you're using

Telehealth follow-up sessions Virtual check-ins to review progress, answer questions, and ensure your plan stays aligned with your goals

2025;48:zsae280

PlexusDx providers follow evidence-based titration protocols that minimize side effects while achieving therapeutic benefit
